PLCG1 (Phospholipase C Gamma 1) encodes a key signaling enzyme that hydrolyzes phosphatidylinositol 4,5-bisphosphate (PIP2) to generate diacylglycerol (DAG) and inositol 1,4,5-trisphosphate (IP3). This phospholipase C isoform is uniquely activated by receptor tyrosine kinases (RTKs) via its tandem SH2 domains, making it a critical bridge between growth factor signaling and intracellular calcium mobilization. In the brain, PLCG1 participates in synaptic transmission, neuronal development, and neuroplasticity, while dysregulation contributes to neurodegenerative disease pathogenesis.
**Symbol:** PLCG1
**Full Name:** Phospholipase C Gamma 1
**Chromosomal Location:** 20q12-q13.11
**NCBI Gene ID:** [5335](https://www.ncbi.nlm.nih.gov/gene/5335)
**OMIM:** [172420](https://www.omim.org/entry/172420)
**Ensembl ID:** ENSG00000124181
**UniProt ID:** [P19174](https://www.uniprot.org/uniprot/P19174)
**Associated Diseases:** Alzheimer's disease, Parkinson's disease, Schizophrenia, Cancer
¶ Protein Structure and Function
¶ Catalytic Domains
PLCG1 is a 1290-amino acid protein with a modular domain architecture:
- X domain: Phosphorylase C-like phosphodiesterase core that catalyzes PIP2 hydrolysis
- Y domain: Regulatory accessory domain required for catalytic activity
- C2 domain: Calcium-dependent membrane targeting
- SH2 domain (x2): Tandem Src homology 2 domains for RTK binding and phosphotyrosine recognition
- SH3 domain: Proline-rich region for cytoskeletal protein interactions
PLCG1 activation involves multiple steps:
- RTK autophosphorylation: Growth factor binding triggers RTK autophosphorylation on specific tyrosine residues
- SH2 domain binding: The tandem SH2 domains of PLCg1 bind to phosphotyrosine motifs on activated RTKs or adapter proteins
- Phosphorylation: PLCg1 is phosphorylated on multiple tyrosine residues (Tyr771, Tyr783, Tyr1254) by the RTK
- Membrane recruitment: C2 domain and membrane PIP2 interactions bring PLCg1 to the plasma membrane
- Catalytic activation: Phosphorylation and membrane localization activate the catalytic X domain
Activated PLCg1 produces two crucial second messengers:
- DAG: Remains in the membrane, activates protein kinase C (PKC) and related kinases
- IP3: Diffuses to the endoplasmic reticulum, triggering calcium release via IP3 receptors
PLCG1 is heavily implicated in Alzheimer's disease pathogenesis through multiple mechanisms:
- APP processing: PLCg1 influences amyloid precursor protein (APP) processing through PKC-dependent pathways. PKC activation promotes non-amyloidogenic alpha-secretase cleavage, while PLCg1 dysregulation shifts processing toward amyloidogenic beta- and gamma-secretase pathways.
- Calcium dysregulation: Aβ oligomers cause excessive PLCg1 activation, leading to IP3-mediated calcium release from ER stores. This calcium dysregulation contributes to excitotoxicity and neuronal death.
- Synaptic dysfunction: PLCg1-mediated signaling is essential for synaptic plasticity. In AD, Aβ-induced PLCg1 hyperactivation disrupts long-term potentiation (LTP) and memory formation.
- Tau pathology: PKC activation by DAG modulates GSK-3β activity, directly affecting tau phosphorylation. PLCg1 dysregulation thus contributes to neurofibrillary tangle formation.
In Parkinson's disease, PLCg1 participates in:
- Dopaminergic signaling: PLCg1 modulates dopamine receptor signaling in striatal medium spiny neurons. Dysregulation affects motor control and reward processing.
- α-Synuclein aggregation: Calcium dysregulation caused by PLCg1 hyperactivation promotes α-synuclein aggregation and toxicity.
- Mitochondrial dysfunction: PLCg1-mediated calcium signals influence mitochondrial health and can trigger apoptotic pathways in dopaminergic neurons.
PLCG1 variants and dysregulation have been linked to ALS:
- Motor neuron vulnerability: PLCg1 signaling affects excitability and survival of motor neurons
- Glial contributions: Astrocytic PLCg1 regulates glutamate uptake; dysregulation contributes to excitotoxicity
- TDP-43 pathology: PLCg1 interacts with RNA granules; its dysregulation may contribute to TDP-43 aggregation
PLCG1 plays essential roles in synaptic transmission:
- Presynaptic vesicle release: IP3-mediated calcium release modulates vesicle fusion and neurotransmitter release
- Synaptic plasticity: DAG-PKC signaling is crucial for LTP and long-term depression (LTD)
- Retrograde signaling: Endocannabinoid release involves PLCg1-dependent pathways
PLCG1 integrates signals from multiple receptor types:
| Receptor |
PLCg1 Role |
Neurobiological Effect |
| TrkA/B |
Direct activation |
NGF/BDNF signaling |
| EGFR |
Indirect activation |
Growth factor responses |
| mGluR1/5 |
Gq-coupled activation |
Glutamate signaling |
| 5-HT2A |
Gq-coupled activation |
Serotonin modulation |
| D1/D5 |
Gq-coupled activation |
Dopamine modulation |
PLCG1 represents a therapeutic target for neurodegenerative diseases:
- PKC inhibitors: PKC modulators indirectly affect PLCg1 downstream signaling
- IP3 receptor antagonists: Drugs targeting IP3 receptors can prevent excessive calcium release
- Calcium stabilizers: Compounds that buffer intracellular calcium may counteract PLCg1 dysregulation
Several PLC inhibitors have been developed:
- U73122: Classic PLC inhibitor, though limited by poor selectivity
- Edelfosine: Alkylphospholipid that inhibits PLCg1
- D609: Selective for PLCg1 over other PLC isoforms
| Protein |
Interaction Type |
Functional Consequence |
| PDGFR |
Direct binding |
Growth factor activation |
| EGFR |
Direct binding |
Growth factor activation |
| TrkA |
Direct binding |
NGF signaling |
| PKCα |
DAG-dependent |
Signal transduction |
| Src |
Tyrosine phosphorylation |
Activation regulation |
- LAT: Linker for activation of T cells, scaffolds PLCg1 in immune cells
- SLP-76: Cooperates with LAT in signaling complexes
- Grb2: Adapter protein that recruits PLCg1 to RTKs
PLCG1 is widely expressed in the brain with highest levels in:
- Hippocampus: Particularly CA1 and dentate gyrus, regions critical for memory
- Cerebral cortex: Layer-specific expression patterns
- Cerebellum: Purkinje cells show high expression
- Striatum: Medium spiny neurons express PLCg1
- Neurons: High expression in excitatory and inhibitory neurons
- Astrocytes: Moderate expression, participates in calcium signaling
- Microglia: Activation-dependent expression
- Oligodendrocytes: Myelination-associated expression
PLCG1 activation triggers multiple signaling cascades:
Growth Factor → RTK → PLCg1 → DAG + IP3
↓
┌──────┴──────┐
↓ ↓
PKC Activation Ca²⁺ Release
↓ ↓
┌──────┴──────┐ ↓
↓ ↓ ↓
MAPK/ERK Gene Expression Exocytosis
Activation (CREB) Synaptic Transmission
PLCG1 interacts with numerous signaling pathways:
- MAPK/ERK pathway: PKC activation leads to Raf/MEK/ERK activation
- PI3K/Akt pathway: Cross-talk regulates cell survival
- Calcium/calmodulin pathways: Calcium influx activates calcineurin and CaMKII
| Disease |
Variant |
Effect |
Reference |
| Alzheimer's disease |
rs2293309 |
Risk modification |
GWAS |
| Parkinson's disease |
rs1249768 |
Altered expression |
eQTL study |
| Schizophrenia |
rs6011300 |
Association |
GWAS |
PLCG1 activity in cerebrospinal fluid may serve as a biomarker for synaptic dysfunction in neurodegenerative diseases. Phosphorylated PLCg1 levels correlate with disease severity in some contexts.
- Knockout mice: Plcg1 knockout is embryonic lethal; conditional knockouts reveal neuronal functions
- iPSC models: Patient-derived neurons allow study of PLCg1 variants
- Organoid systems: Brain organoids reveal developmental roles